Literature DB >> 18976676

Impaired microvascular endothelial function is restored by acute lower-limb exercise in post-surgical varicose vein patients.

Markos Klonizakis1, Garry Tew, Jonathan Michaels, John Saxton.   

Abstract

Evidence exists that cutaneous microvascular endothelial dysfunction persists in patients following varicose vein surgery. This study compared cutaneous microvascular function between post-surgical varicose vein patients and healthy controls and investigated whether any impairment of function can be attenuated by acute lower-limb exercise. Cutaneous flux responses of the gaiter area were measured in supine and standing positions before and after a 25-min walk using laser Doppler fluximetry and incremental-dose administration of acetylcholine (ACh) and sodium nitroprusside (SNP). The pre-exercise peak responses to ACh (standing) were lower in patients than controls (48+/-11 vs. 96+/-28 PU; P=0.032), whereas treadmill exercise abolished this difference (P=0.819). In contrast, the pre-exercise responses to SNP (standing) appeared higher in patients than controls (3 mC responses: 24+/-4 vs. 10+/-2 PU, respectively; P=0.023), with no effect of acute exercise (P>0.05). These findings suggest that acute treadmill exercise augments microvascular endothelial function in post-surgical varicose vein patients to levels observed in age-matched controls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976676     DOI: 10.1016/j.mvr.2008.09.009

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  8 in total

1.  Effects of ageing and fitness on skin-microvessel vasodilator function in humans.

Authors:  Garry A Tew; Markos Klonizakis; John M Saxton
Journal:  Eur J Appl Physiol       Date:  2010-01-05       Impact factor: 3.078

2.  Effects of upper-limb exercise on lower-limb cutaneous microvascular function in post-surgical varicose-vein patients.

Authors:  Markos Klonizakis; Garry A Tew; Jonathan A Michaels; John M Saxton
Journal:  Eur J Appl Physiol       Date:  2010-04-10       Impact factor: 3.078

3.  Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice.

Authors:  Adrian Gericke; Jan J Sniatecki; Veronique G A Mayer; Evgeny Goloborodko; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

4.  Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice.

Authors:  Adrian Gericke; Veronique G A Mayer; Andreas Steege; Andreas Patzak; Ulrike Neumann; Franz H Grus; Stephanie C Joachim; Lars Choritz; Jürgen Wess; Norbert Pfeiffer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

5.  The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.

Authors:  A Mitropoulos; A Gumber; H Crank; M Akil; M Klonizakis
Journal:  Arthritis Res Ther       Date:  2018-06-05       Impact factor: 5.156

6.  Investigating the effectiveness and feasibility of exercise on microvascular reactivity and quality of life in systemic sclerosis patients: study protocol for a feasibility study.

Authors:  Alexandros Mitropoulos; Anil Gumber; Helen Crank; Mohammed Akil; Markos Klonizakis
Journal:  Trials       Date:  2018-11-21       Impact factor: 2.279

Review 7.  Global impact and contributing factors in varicose vein disease development.

Authors:  Muhammad Rahil Aslam; Hafiz Muhammad Asif; Khalil Ahmad; Sana Jabbar; Abdul Hayee; Muhammad Shahid Sagheer; Jalil Ur Rehman; Sana Khalid; Abdul Sattar Hashmi; Sehrish Rana Rajpoot; Aamir Sharif
Journal:  SAGE Open Med       Date:  2022-08-25

8.  Supervised exercise training as an adjunctive therapy for venous leg ulcers: study protocol for a randomised controlled trial.

Authors:  Garry A Tew; Jonathan Michaels; Helen Crank; Geoff Middleton; Anil Gumber; Markos Klonizakis
Journal:  Trials       Date:  2015-10-06       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.